Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Developing a viability index for machine-perfused livers

Official title: Development of a Liver Viability Index for Transplantation

Run by Massachusetts General Hospital · NCT03694691 · Data updated 2026-11-12

This study is testing a new way to see if discarded livers can be successfully transplanted by using machine technology to check their health before giving them to patients in need of a liver transplant.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment60 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedOctober 1, 2018
Main results expectedDecember 1, 2028
Study endsJune 1, 2030
Registry record updatedNovember 3, 2025
Trial IDNCT03694691 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 18-75 who are awaiting a deceased-donor liver transplant.

Probably not a fit

Patients who are HIV-1 positive will not benefit from this study due to exclusion criteria.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to improve the transplantability of discarded liver grafts using machine perfusion technology. By collecting biopsies from livers before and after transplantation, researchers will analyze metabolite and gene expression data to establish a viability index. This index will help determine which machine-perfused livers can be successfully transplanted, potentially increasing the availability of donor organs. The study focuses on patients who are candidates for deceased-donor liver allografts.

Why it matters

Potential benefit: If successful, this study could significantly increase the number of viable livers available for transplantation, improving outcomes for patients with liver cirrhosis.

How similar studies have gone: While machine perfusion technology is being explored in other studies, the development of a specific viability index for liver grafts post-machine perfusion is a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female 18-75 years of age.
* Candidate for a deceased-donor liver allograft.

Exclusion Criteria:

* Seropositivity for HIV-1.

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.